Sanofi-Aventis S.A. ADR (SNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 14,100,270 | 15,394,410 | 12,186,370 | 11,173,420 | 8,028,906 |
| Cost of Goods | 4,334,137 | 3,988,287 | 3,397,654 | 3,043,562 | 2,391,313 |
| Gross Profit | 9,766,141 | 11,406,130 | 8,788,719 | 8,129,859 | 5,637,596 |
| Operating Expenses | 8,641,230 | 7,084,990 | 6,848,180 | 5,687,354 | 4,584,102 |
| Operating Income | 1,125,049 | 4,321,423 | 1,941,192 | 2,443,066 | 1,053,805 |
| Interest Expense | -20,767 | 265,340 | 168,010 | 224,396 | 236,409 |
| Other Income | -2,417,192 | 44,419 | -108,979 | 99,030 | -389,389 |
| Pre-tax Income | -1,271,376 | 4,100,501 | 1,664,204 | 2,317,700 | 428,007 |
| Income Tax | -382,631 | 794,852 | 261,096 | 506,734 | -7,605 |
| Net Income Continuous | -888,745 | 3,305,649 | 1,403,107 | 1,810,967 | 435,612 |
| Net Income Discontinuous | 18,726 | -23,378 | 3,072,986 | 183,309 | N/A |
| Minority Interests | 9,316 | 7,013 | 4,541 | 22,124 | 12,452 |
| Net Income | $-879,335 | $3,275,258 | $4,471,553 | $1,972,152 | $492,414 |
| EPS Basic Total Ops | -0.36 | 1.34 | 1.84 | 0.80 | 0.19 |
| EPS Basic Continuous Ops | -0.36 | 1.36 | 0.58 | 0.73 | 0.17 |
| EPS Basic Discontinuous Ops | 0.01 | -0.01 | 1.26 | 0.07 | N/A |
| EPS Diluted Total Ops | -0.38 | 1.34 | 1.84 | 0.80 | 0.19 |
| EPS Diluted Continuous Ops | -0.37 | 1.36 | 0.58 | 0.73 | 0.17 |
| EPS Diluted Discontinuous Ops | 0.00 | -0.01 | 1.26 | 0.07 | N/A |
| EPS Diluted Before Non-Recurring Items | 0.89 | 1.70 | 0.90 | 0.94 | 0.70 |
| EBITDA(a) | $1,125,049 | $4,321,423 | $1,941,192 | $2,443,066 | $1,053,805 |